Breaking News Instant updates and real-time market news.

JCOM

j2 Global

$87.24

1.02 (1.18%)

, IRBT

iRobot

$68.31

2.38 (3.61%)

04:55
06/07/18
06/07
04:55
06/07/18
04:55

Citigroup to hold a conference

2018 Small & Mid-Cap Conference will be held in New York on June 6-7.

JCOM

j2 Global

$87.24

1.02 (1.18%)

IRBT

iRobot

$68.31

2.38 (3.61%)

EFII

Electronics for Imaging

$34.74

0.15 (0.43%)

PTC

PTC

$89.26

0.97 (1.10%)

QLYS

Qualys

$80.55

-0.3 (-0.37%)

EEX

Emerald Expositions Events

$21.50

0.33 (1.56%)

MKSI

MKS Instruments

$118.60

1 (0.85%)

VG

Vonage

$11.55

-0.105 (-0.90%)

TYL

Tyler Technologies

$235.75

-0.1 (-0.04%)

TRHC

Tabula Rasa HealthCare

$55.03

-1.12 (-1.99%)

NTCT

NetScout

$27.15

0.15 (0.56%)

USPH

U.S. Physical Therapy

$97.35

0.65 (0.67%)

  • 07

    Jun

  • 07

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 18

    Jun

  • 19

    Jun

JCOM j2 Global
$87.24

1.02 (1.18%)

05/09/18
DADA
05/09/18
NO CHANGE
Target $100
DADA
Buy
j2 Global price target raised to $100 from $95 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on J2 Global to $100 after its Q1 earnings, saying the results were driven by a 16% revenue increase in digital media. The analyst notes that the segment is increasingly more focused on subscription revenue, which has grown to 22% of digital media's total sales from 12% last quarter, adding that EBITDA margins are also expected to improve after some compression in Q1. Jaluria keeps his Buy rating on J2 Global.
02/02/18
DADA
02/02/18
INITIATION
Target $95
DADA
Buy
j2 Global initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated j2 Global with a Buy rating and a price target of $95, saying the company acquisition strategy is akin to private equity in "buying underperforming assets in cloud services and digital media and achieving scale through a roll-up strategy". The analyst is also positive on j2 Global's operating margin expansion and potential for further gains along with its attractive valuation relative to the peer group.
IRBT iRobot
$68.31

2.38 (3.61%)

05/16/18
PIPR
05/16/18
NO CHANGE
Target $78
PIPR
Overweight
iRobot checks show reduced in-stock levels, says Piper Jaffray
Piper Jaffray analyst Troy Jensen says a recent round of channel checks showed iRobot's in-stock levels dropped following Mother's Day weekend sales across U.S. retailers, indicating solid sales volume. The analyst believes the company's Q2 sales will be in-line or potentially above expectations. Further, based on recent patents granted to iRobot, Jensen believes the company's new products in the second half of 2018 will include a new high-end Roomba with an evacuation station to automatically empty the debris bin. He believes this new feature would add "significant value" to the Roomba product. The analyst remains upbeat on iRobot shares with an Overweight rating and $78 price target.
04/19/18
04/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Buy from Hold at Argus with analyst Christopher Graja saying he believes an improving job market should help low-and-middle-income shoppers spend more. 2. Sprint (S) upgraded to Neutral from Underperform at Macquarie. 3. iRobot (IRBT) upgraded to Overweight from Neutral at Piper Jaffray with analyst Troy Jensen saying tracking data shows iRobot is experiencing "exceptionally strong demand in North America." 4. Diodes (DIOD) upgraded to Buy from Neutral at Longbow with analyst Shawn Harrison saying he expects rising demand, pricing, and Pericom growth to drive sales, gross margins, and earnings higher. 5. Texas Capital (TCBI) upgraded to Overweight from Neutral at Piper Jaffray with analyst Brett Rabatin saying he sees Texas Capital outperforming peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/28/18
NORL
02/28/18
NO CHANGE
Target $86
NORL
Outperform
Buying iRobot would be 'logical next step' for Amazon, says Northland
After Amazon (AMZN) acquired a smart camera company Blink last year and reportedly agreed this week to buy smart security company Ring, Northland analyst Michael Latimore said he thinks a "logical next step" would be for the e-commerce giant to buy iRobot (IRBT) and add more smart home products to sell. The analyst, who said he expects additional color tomorrow during the company's analyst day on their "rich AI tech" and product roadmap, has an Outperform rating on iRobot shares.
04/18/18
PIPR
04/18/18
UPGRADE
PIPR
Overweight
iRobot upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen upgraded iRobot to Overweight from Neutral and increased his price target to $78 from $63. Jensen said that tracking data shows iRobot is experiencing "exceptionally strong demand in North America," and he believes the demand is likely share gains for the new Shark and Neato products as well as better than expected demand for Roomba vacuums for the March quarter. Jensen also believes new product introductions in the second half of the year and increased marketing spending in Europe and for the BraavaJet will provide additional tailwinds for iRobot.
EFII Electronics for Imaging
$34.74

0.15 (0.43%)

01/10/18
LEHM
01/10/18
UPGRADE
Target $67
LEHM
Overweight
Lumentum upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Joseph Wolf upgraded Lumentum (LITE) to Overweight and raised his price target for the shares to $67 from $65. The analyst coupled the upgrade with a downgrade this morning of Electronics for Imaging (EFII) to Underweight from Equal Weight. Lumentum remains the market share leader at Apple (AAPL) and seems well positioned to take advantage of other opportunities, Wolf tells investors in a research note. He thinks investors should take advantage of the current stock price to add to positions in anticipation of strong results for the next 12-18 months.
01/10/18
LEHM
01/10/18
DOWNGRADE
Target $31
LEHM
Underweight
Electronics for Imaging downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Joseph Wolf downgraded Electronics for Imaging to Underweight and cut his price target for the shares to $31 from $33. The analyst believes the company needs "close to flawless" execution as a minimum requirement for the shares to perform. He sees relatively high risk in the stock.
12/27/17
NEED
12/27/17
NO CHANGE
NEED
Electronics for Imaging, Kornit among Needham's top Advanced Industrial ideas
Needham analyst James Ricchiuti noted that stocks the firm covers in the Advanced Industrial Technologies space saw "a remarkable performance" in 2017. The economic backdrop seems "brighter than at any time since before the Great Recession" and he believes many of the same underlying growth drivers will remain in place in 2018. The top ideas for 2018 he highlighted include Electronics for Imaging (EFII), Kornit Digital (KRNT), II-VI (IIVI), Zebra Technologies (ZBRA) and Impinj (PI).
11/14/17
WELS
11/14/17
INITIATION
WELS
Market Perform
Electronics for Imaging initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Aaron Rakers initiated coverage of Electronics for Imaging with a Market Perform rating and $32 price target.
PTC PTC
$89.26

0.97 (1.10%)

04/23/18
BREN
04/23/18
NO CHANGE
Target $100
BREN
Buy
PTC price target raised to $100 from $80 at Berenberg
Berenberg analyst Gal Munda raised his price target for PTC to $100 ahead of the company's investor day in June. Management could raise their fiscal 2021 free cash flow target of $525M by 10%, Munda tells investors in a research note. He notes that PTC's revenue, profitability, and cash metrics are now coming ahead of guidance. The analyst recommends buying the stock ahead of the investor day and keeps a Buy rating on the name.
04/19/18
BARD
04/19/18
NO CHANGE
Target $95
BARD
Outperform
PTC price target raised to $95 from $83 at Baird
Baird analyst Rob Oliver raised his price target on PTC to $95 from $83 following Q2 results. The analyst noted the company reported in-line bookings and maintained the full-year bookings outlook and noted Q3 guidance was above consensus. Oliver reiterated his Outperform rating on PTC shares.
04/18/18
MUFG
04/18/18
NO CHANGE
Target $67
MUFG
Neutral
PTC price target raised to $67 from $50 at MUFG
MUFG analyst Stephen Bersey raised his price target on PTC to $67 after the company's Q1 earnings beat that showed "continued strength in its core business". Bersey adds that PTC appears to be near completion in its subscription model shift , anticipating mid-single digit revenue growth going forward. The analyst keeps his Neutral rating on PTC longer term on concerns around the growth potential of its non-core business units.
04/16/18
RBCM
04/16/18
NO CHANGE
Target $85
RBCM
Outperform
PTC price target raised to $85 from $80 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target on PTC (PTC) to $85 and kept his Outperform rating ahead of the company's Q2 earnings. Hedberg says PTC should should build on its strong start to the year with continued execution amid a "solid macro environment". The analyst points to better traction for the company's Internet of Things products as well as potential benefits from its partnership with Microsoft's (MSFT) Azure, along with "above-market-growth from the solutions business on improved direct/indirect selling".
QLYS Qualys
$80.55

-0.3 (-0.37%)

04/24/18
NEED
04/24/18
NO CHANGE
Target $95
NEED
Buy
Qualys price target raised to $95 from $85 at Needham
Needham analyst Alex Henderson raised his price target on Qualys to $95 and kept his Buy rating after his week at the RSA Security Conference that reinforced the trends of strengthening demand, increased security spending amid digital transformation, and boards becoming more engaged around data breach risks and upcoming GDPR data protection regulations. Henderson says the company was one of the few to host an analyst meeting at the event, and its presentation provided a positive outlook for its technology, automation and new product flow. The analyst also cites the company's market share growth among the Fortune 50 companies, as 74% of these firms adopted Qualys Cloud Platform vs. 68% in year ago period.
03/06/18
NEED
03/06/18
NO CHANGE
Target $85
NEED
Buy
Qualys price target raised to $85 from $80 at Needham
Needham analyst Alex Henderson raised his price target on Qualys to $85, saying his recent meeting with the management gave him added confidence in the company's 2018 prospects and beyond. Henderson says the company's core business in Vulnerability Management is accelerating while its new products are seeing greater traction, leading to larger initial deals. The analyst keeps his Buy rating on Qualys amid robust up-sell opportunities along with a better acceptance rate overseas.
02/15/18
NEED
02/15/18
NO CHANGE
Target $80
NEED
Buy
Qualys price target raised to $80 from $70 at Needham
Needham analyst Alex Henderson raised his price target on Qualys to $80 from $70 after better than expected Q4 results and a strong outlook for Q1, driven by strong adoption of new products and broadening customer spending. The analyst keeps his Buy rating on Qualys, noting that the company's operating margins will remain strong despite investing ahead for future growth.
02/13/18
WELS
02/13/18
NO CHANGE
Target $62
WELS
Market Perform
Qualys price target raised to $62 from $52 at Wells Fargo
Wells Fargo analyst Siti Panigrahi raised his price target for Qualys to $62 from $52 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
EEX Emerald Expositions Events
$21.50

0.33 (1.56%)

05/03/18
05/03/18
NO CHANGE

Emerald Expositions Events reports Q1 adjusted EPS 66c, consensus 63c
Reports Q1 revenue $142.2M, consensus $140.5M.
03/14/18
GSCO
03/14/18
UPGRADE
Target $20.2
GSCO
Neutral
Emerald Expositions Events upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Katherine Tait upgraded Emerald Expositions Events to Neutral from Sell on valuation, saying the recent underperformance in the stock price has taken its forward PE multiple to 16.3-times from 19-times earlier this year. Tait adds that this multiple more fairly reflects the growth and outlook for the company relative to its peers. The analyst maintains its other forecasts, anticipating 2018 organic growth of 2% while also keeping her price target on the stock at $20.20.
01/23/18
GSCO
01/23/18
DOWNGRADE
GSCO
Sell
Emerald Expositions Events downgraded to Sell from Neutral at Goldman Sachs
MKSI MKS Instruments
$118.60

1 (0.85%)

05/14/18
COWN
05/14/18
INITIATION
Target $135
COWN
Outperform
MKS Instruments initiated with an Outperform at Cowen
Cowen initiated MKS Instruments with an Outperform and $135 price target.
04/25/18
STFL
04/25/18
NO CHANGE
Target $147
STFL
Buy
MKS Instruments price target raised to $147 from $133 at Stifel
04/18/18
STFL
04/18/18
NO CHANGE
STFL
Lam reiteration of WFE view not a negative sign, says Stifel
Stifel analyst Patrick Ho acknowledged that Lam Research (LRCX) did not provide any significant "new" news related to 2018 wafer fab equipment spending and reiterated its previous guidance of low double-digit year-over-year growth with only a modest change in mix. However, this reiteration is not a negative sign on the current environment or 2018 as a whole, said Ho, who advises using any selloff in the group following Lam's report as a buying opportunity. He continues to prefer Applied Materials (AMAT) and MKS Instruments (MKSI) as his most preferred names in Semiconductor Capital Equipment, while also having Buy ratings on Lam Research and Entegris (ENTG).
05/31/18
BNCH
05/31/18
INITIATION
Target $140
BNCH
Buy
MKS Instruments initiated with a Buy at Benchmark
Benchmark analyst Mark Miller initiated MKS Instruments with a Buy rating, citing his positive view of the growth opportunities from the 62 semiconductor equipment fabs and lines planned by 2020, the company's laser products, and its growing global service business. Miller set a $140 price target on MKS Instruments shares.
VG Vonage
$11.55

-0.105 (-0.90%)

11/08/17
SBSH
11/08/17
NO CHANGE
Target $11
SBSH
Buy
Vonage price target raised to $11 from $9.75 at Citi
Citi analyst Michael Rollins raised his price target for Vonage Holdings to $11 citing an improved outlook following the company's Q3 results. The quarter shows execution of the company's strategic plan to generate cash from Consumer while investing in Business is on track, Rollins tells investors in a post-earnings research note. He says the stock at current levels remains at a significant valuation discount to UCaaS and CPaaS peers. The analyst keeps a Buy rating on Vonage.
01/25/18
CHLM
01/25/18
NO CHANGE
CHLM
8x8, Inc., Vonage marriage makes 'great sense,' says Craig-Hallum
Craig-Hallum analyst George Sutton notes that while never confirmed, it was widely believed that 8x8 (EGHT) had entertained interest from third parties back about a year ago, and more recently, Vonage (VG) has expressed desire to pursue a "transformational acquisition." There are only a few acquisitions possible in this market that the analyst feel would fit the definition and 8x8 clearly would be one, he contends. Importantly, Sutton believes it makes sense on a number of strategic bases.
12/20/17
OPCO
12/20/17
NO CHANGE
Target $52
OPCO
Outperform
GTT Communications price target raised to $52 from $39 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for GTT Communications (GTT) to $52 from $39, while reiterating an Outperform rating on the shares. The analyst believes M&A activity should shift from large- to small-cap with GTT, Cogent (CCOI), Boingo Wireless (WIFI), Akamai (AKAM), Interxion (INXN) and Vonage (VG) all attractive targets with strong fundamentals.
12/11/17
NEED
12/11/17
NO CHANGE
Target $12
NEED
Buy
Vonage businesses to benefit from secular tailwinds and momentum, says Needham
Needham analyst Richard Valera raised his price target on Vonage to $12 from $10 and kept his Buy rating, saying the company remains his top pick in the space for 2018. Valera anticipates "secular tailwinds and solid business momentum in the UCaaS and CPaaS businesses" at Vonage. The analyst also forecasts strong cash flows from its legacy Consumer business as it de-levers its balance sheet, supporting M&A activity next year.
TYL Tyler Technologies
$235.75

-0.1 (-0.04%)

04/19/18
BNCH
04/19/18
NO CHANGE
Target $250
BNCH
Buy
Tyler Technologies price target raised to $250 after Socrata deal at Benchmark
Benchmark analyst Mark Schappel estimates that Tyler Technologies paid between $110M-$130M to acquire Socrata, a provider of analytics software for government agencies with a focus on enabling connected communities. He thinks the deal fits squarely within Tyler's strategy and complements its current offerings and views the transaction favorably. Schappel raised his price target on Tyler shares to $250 from $225 and reiterates a Buy rating on the shares.
04/24/18
NORL
04/24/18
NO CHANGE
Target $240
NORL
Outperform
Tyler Technologies price target raised to $240 from $200 at Northland
Northland analyst Tim Klasell raised his price target for Tyler Technologies to $240 from $200 after attending the opening day of its user conference. The analyst notes that the Socrata acquisition was highlighted at the management meeting, and while small he thinks it will be leveraged across most of Tyler's product line. Klasell reiterates an Outperform rating on the shares.
04/24/18
NEED
04/24/18
NO CHANGE
Target $250
NEED
Buy
Tyler Technologies price target raised to $250 from $235 at Needham
Needham analyst Scott Berg raised his price target on Tyler Technologies to $250 and kept his Buy rating, citing his observations from the company's annual customer conference yesterday. Berg notes that local government spending looks to remain above-average, driving Tyler Technologies' 10% or more organic revenue growth. The analyst also sees Socrata acquisition producing a "home run" once integration is completed in 2-3 years.
04/23/18
DADA
04/23/18
NO CHANGE
Target $200
DADA
Neutral
Tyler Technologies price target raised to $200 from $190 at DA Davidson
DA Davidson analyst Peter Heckmann raised his price target on Tyler Technologies to $200 ahead of the company's Q1 earnings next week which he expects to produce a modest beat. The analyst is also building the acquisition of Socrata announced last week into his model, though he also warns that in the near term the integration will produce some margin pressure. Heckmann keeps his Neutral rating on Tyler Technologies.
TRHC Tabula Rasa HealthCare
$55.03

-1.12 (-1.99%)

05/09/18
PIPR
05/09/18
NO CHANGE
Target $46
PIPR
Overweight
Tabula Rasa HealthCare price target raised to $46 form $43 at Piper Jaffray
Piper Jaffray analyst Sean Wieland believes Tabula Rasa HealthCare is in the "right place at the right time" as the dialogue around pharmacy risk is accelerating. The focus is on executing in the health plan market, and delivering a needed capability to address the opiod crisis, Wieland tells investors in a post-earnings research note. He raised his price target for the shares to $46 and reiterates an Overweight rating on Tabula following its Q1 results.
05/09/18
SBSH
05/09/18
NO CHANGE
Target $57
SBSH
Buy
Tabula Rasa HealthCare price target raised to $57 from $48 at Citi
Citi analyst Stephanie Demko raised her price target for Tabula Rasa HealthCare to $57 citing the company's "solid" Q1 results. The guidance raise was solely for the beat and the Peak PACE deal, which could prove conservative provided the company continues to execute, Demko tells investors in a research note. She reiterates a Buy rating on the shares.
04/10/18
FANA
04/10/18
NO CHANGE
Target $47
FANA
Overweight
First Analysis remains bullish on Tabula Rasa after management meetings
First Analysis analyst Frank Sparacino remains bullish on shares of Tabula Rasa HealthCare after hosting investor meetings with the company's CFO Brian Adams. The analyst reiterates an Overweight rating on the shares with a $47 price target. Tabula Rasa has a "unique" competitive position and a favorable secular backdrop with medication management and pharmacists playing a more integral role in value-based care, Sparacino tells investors in a research note. He sees the potential for 2018 revenue outperformance and thinks the company's organic revenue growth can exceed 20%. The analyst calls the latter a "rarity in the broader healthcare IT landscape today."
05/21/18
OPCO
05/21/18
NO CHANGE
Target $63
OPCO
Outperform
Tabula Rasa HealthCare price target raised to $63 from $47 at Oppenheimer
Oppenheimer analyst Mohan Naidu raised his price target for Tabula Rasa HealthCare to $63 from $47 as he is more convinced that the company's unique approach can make personalized medicine mainstream. The analyst reiterates an Outperform rating on the shares.
NTCT NetScout
$27.15

0.15 (0.56%)

01/17/18
DADA
01/17/18
NO CHANGE
Target $8
DADA
Buy
A10 Networks price target lowered to $8 at DA Davidson on soft Q4 revenue view
DA Davidson analyst Mark Kelleher lowered his price target on A10 Networks (ATEN) to $8 from $9 but kept his Buy rating after the company's preliminary Q4 results lowering expectations for sales. The analyst says the company "may have been caught in 4Q by weakness in the Service Provider sector" - similarly to NetScout (NTCT) - but believes the weakness may be temporary. Longer term, Kelleher notes that A10 Networks offers "unique solutions in the cyber security market, particularly with the DDoS threat vector" and can achieve profitable growth in 2018 and beyond.
04/09/18
PIPR
04/09/18
NO CHANGE
PIPR
Overweight
Piper networking channel survey 'very positive' for Cisco
Piper Jaffray analyst James Fish collected feedback from 43 networking channel partners for a Q1 channel survey. Overall results were mixed across the sector but "very positive" for Cisco Systems (CSCO), Fish tells investors in a research note. Cisco had 43% of partners above plan and only 3% below plan, with strong Q2 seasonality, the analyst writes. Further, he points out that results for Arista Networks (ANET) suggest upside to guidance amid increasing router sales. Results for F5 Networks (FIIV) were mixed, while Juniper Networks (JNPR), Mellanox (MLNX) and NetScout (NTCT) were weak, Fish adds. He calls Cisco his number one draft pick.
01/11/18
RBCM
01/11/18
NO CHANGE
Target $27
RBCM
Sector Perform
NetScout price target lowered to $27 from $33 at RBC Capital
RBC Capital analyst Matthew Hedberg lowered his price target on NetScout to $27 after the company's below-consensus FY18 outlook and soft Q3 guidance. The analyst says the service provider spending in North America remains under "significant pressure", and weakness is expected to carry over into Q4 and possibly FY19. Hedberg keeps his Sector Perform rating on NetScout.
01/11/18
DADA
01/11/18
DOWNGRADE
Target $27
DADA
Neutral
NetScout downgraded to Neutral from Buy at DA Davidson
As reported previously, DA Davidson analyst Mark Kelleher downgraded NetScout Systems to Neutral from Buy and lowered his price target to $27 from $37. Kelleher cites the company's preliminary Q3 report that indicated further slowness in capital expenditure for network assurance products. While NetScout is countering the slower spend with more share buybacks, the analyst contends that this implies on-going softness in the company's end markets.
USPH U.S. Physical Therapy
$97.35

0.65 (0.67%)

03/09/18
CANT
03/09/18
NO CHANGE
Target $90
CANT
Overweight
U.S. Physical Therapy price target raised to $90 from $80 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph France raised his price target for U.S. Physical Therapy to $90 citing improved margins and a lower tax rate. The analyst reiterates an Overweight rating on the shares following the company's better than expected Q4 results.
05/04/18
CANT
05/04/18
DOWNGRADE
CANT
Neutral
U.S. Physical Therapy downgraded to Neutral from Overweight at Cantor Fitzgerald
05/04/18
CANT
05/04/18
DOWNGRADE
Target $90
CANT
Neutral
U.S. Physical Therapy downgraded to Neutral on valuation at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph France downgraded U.S. Physical Therapy to Neutral with Overweight with an unchanged price target of $90. The analyst believes the shares are fully valued following the company's inline Q1 results.
04/25/18
SIDC
04/25/18
DOWNGRADE
SIDC
Neutral
U.S. Physical Therapy downgraded to Neutral from Buy at Sidoti

TODAY'S FREE FLY STORIES

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$18.21

-0.27 (-1.46%)

17:17
09/21/18
09/21
17:17
09/21/18
17:17
Hot Stocks
Breaking Hot Stocks news story on Voyager Therapeutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNRC

Generac

$57.99

-0.02 (-0.03%)

17:16
09/21/18
09/21
17:16
09/21/18
17:16
Hot Stocks
Generac announces new $250M share repurchase program »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

, IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

17:13
09/21/18
09/21
17:13
09/21/18
17:13
Conference/Events
Independent Bank to host special shareholder meeting »

Special Shareholder…

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

HRS

Harris

$164.33

1.685 (1.04%)

17:13
09/21/18
09/21
17:13
09/21/18
17:13
Hot Stocks
Harris awarded $255.4M Department of Defense contract »

Harris Corp has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PMBC

Pacific Mercantile Bancorp

$9.25

-0.5 (-5.13%)

17:10
09/21/18
09/21
17:10
09/21/18
17:10
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

FJ Capital Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WSC

WillScot

$17.10

-0.05 (-0.29%)

17:10
09/21/18
09/21
17:10
09/21/18
17:10
Syndicate
Breaking Syndicate news story on WillScot »

WillScot files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DAVIDsTEA

$2.50

-0.9 (-26.47%)

17:09
09/21/18
09/21
17:09
09/21/18
17:09
Hot Stocks
Breaking Hot Stocks news story on DAVIDsTEA »

TDM Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$23.45

0.3 (1.30%)

, EXPE

Expedia

$133.73

-0.77 (-0.57%)

17:08
09/21/18
09/21
17:08
09/21/18
17:08
Hot Stocks
Expedia president Bhutani joins New York Times board »

The New York Times…

NYT

New York Times

$23.45

0.3 (1.30%)

EXPE

Expedia

$133.73

-0.77 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

, GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

17:08
09/21/18
09/21
17:08
09/21/18
17:08
Conference/Events
Guaranty Bancorp to host special shareholder meeting »

Special Shareholder…

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

, ANDV

Andeavor

$154.80

2.19 (1.44%)

17:01
09/21/18
09/21
17:01
09/21/18
17:01
Conference/Events
Andeavor to host special shareholder meeting »

Special Shareholder…

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

ANDV

Andeavor

$154.80

2.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

ANDV

Andeavor

$154.80

2.19 (1.44%)

, MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

16:59
09/21/18
09/21
16:59
09/21/18
16:59
Conference/Events
Marathon Petroleum to host special shareholder meeting »

Special Shareholder…

ANDV

Andeavor

$154.80

2.19 (1.44%)

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EPRT

Essential Properties Realty Trust

$14.49

-0.015 (-0.10%)

16:45
09/21/18
09/21
16:45
09/21/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Essential Properties Realty Trust »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBSI

Barrett Business

$63.67

0.04 (0.06%)

16:43
09/21/18
09/21
16:43
09/21/18
16:43
Hot Stocks
SEC says Barrett Business to pay $1.5M penalty over improper accounting »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIGA

Siga Technologies

$7.25

0.5 (7.41%)

16:42
09/21/18
09/21
16:42
09/21/18
16:42
Conference/Events
Siga Technologies to host business news update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

, USO

United States Oil Fund

$14.95

0.145 (0.98%)

16:36
09/21/18
09/21
16:36
09/21/18
16:36
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 0.1K…

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

FXE

Euro Currency Trust

$112.55

-0.27 (-0.24%)

FXC

CurrencyShares Canadian Dollar Trust

$76.37

-0.09 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.